Labor drug pause may protect newborns
NCT ID NCT03991091
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 35 times
Summary
This study tested whether turning off the labor drug oxytocin once a woman reaches 6 cm dilation (active labor) could lower the chance of newborn complications. Over 2,400 women with a single, full-term baby in head-down position took part. The goal was to see if this simple change in drug timing could improve newborn health outcomes like breathing, blood acidity, and need for intensive care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL MORBIDITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
hospital Cochin; port royal Maternity unit
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.